Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury

NCT01683838 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Cord Injury
Muscle Spasticity

Interventions

DRUG: Fampridine-SR
DRUG: Placebo

Sponsor

Acorda Therapeutics